These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 26731559)

  • 1. MicroRNA-21 expression and its pathogenetic significance in cutaneous melanoma.
    Saldanha G; Potter L; Lee YS; Watson S; Shendge P; Pringle JH
    Melanoma Res; 2016 Feb; 26(1):21-8. PubMed ID: 26731559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-21 regulates the ERK/NF-κB signaling pathway to affect the proliferation, migration, and apoptosis of human melanoma A375 cells by targeting SPRY1, PDCD4, and PTEN.
    Mao XH; Chen M; Wang Y; Cui PG; Liu SB; Xu ZY
    Mol Carcinog; 2017 Mar; 56(3):886-894. PubMed ID: 27533779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examination of mutations in BRAF, NRAS, and PTEN in primary cutaneous melanoma.
    Goel VK; Lazar AJ; Warneke CL; Redston MS; Haluska FG
    J Invest Dermatol; 2006 Jan; 126(1):154-60. PubMed ID: 16417231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NRF1 and NRF2 mRNA and Protein Expression Decrease Early during Melanoma Carcinogenesis: An Insight into Survival and MicroRNAs.
    Hämäläinen M; Teppo HR; Skarp S; Haapasaari KM; Porvari K; Vuopala K; Kietzmann T; Karihtala P
    Oxid Med Cell Longev; 2019; 2019():2647068. PubMed ID: 31687076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.
    Sand M; Skrygan M; Sand D; Georgas D; Gambichler T; Hahn SA; Altmeyer P; Bechara FG
    Cell Tissue Res; 2013 Jan; 351(1):85-98. PubMed ID: 23111773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA expression profiles associated with mutational status and survival in malignant melanoma.
    Caramuta S; Egyházi S; Rodolfo M; Witten D; Hansson J; Larsson C; Lui WO
    J Invest Dermatol; 2010 Aug; 130(8):2062-70. PubMed ID: 20357817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microrna profiling analysis of differences between the melanoma of young adults and older adults.
    Jukic DM; Rao UN; Kelly L; Skaf JS; Drogowski LM; Kirkwood JM; Panelli MC
    J Transl Med; 2010 Mar; 8():27. PubMed ID: 20302635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seed targeting with tiny anti-miR-1297 inhibits EMT in melanoma cells.
    Han Y; Li X; Ma C; Ji X; Li T; Zheng X; Zhang J; Yan J; Zhang D; Bai J
    J Drug Target; 2019 Jan; 27(1):75-81. PubMed ID: 29873263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma.
    Tsao H; Goel V; Wu H; Yang G; Haluska FG
    J Invest Dermatol; 2004 Feb; 122(2):337-41. PubMed ID: 15009714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct MAPK and PI3K pathway mutations in different melanoma types in Taiwanese individuals.
    Gao HW; Tsai WC; Perng CL; Wang WM; Chiang CP
    Eur J Dermatol; 2018 Aug; 28(4):509-518. PubMed ID: 30325319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The High Expression of the microRNA 17-92 Cluster and its Paralogs, and the Downregulation of the Target Gene PTEN, Is Associated with Primary Cutaneous B-Cell Lymphoma Progression.
    Battistella M; Romero M; Castro-Vega LJ; Gapihan G; Bouhidel F; Bagot M; Feugeas JP; Janin A
    J Invest Dermatol; 2015 Jun; 135(6):1659-1667. PubMed ID: 25634356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-146a promotes the initiation and progression of melanoma by activating Notch signaling.
    Forloni M; Dogra SK; Dong Y; Conte D; Ou J; Zhu LJ; Deng A; Mahalingam M; Green MR; Wajapeyee N
    Elife; 2014 Feb; 3():e01460. PubMed ID: 24550252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. microRNA-10b is a prognostic biomarker for melanoma.
    Saldanha G; Elshaw S; Sachs P; Alharbi H; Shah P; Jothi A; Pringle JH
    Mod Pathol; 2016 Feb; 29(2):112-21. PubMed ID: 26743475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-367 promotes uveal melanoma cell proliferation and migration by regulating PTEN.
    Ling JW; Lu PR; Zhang YB; Jiang S; Zhang ZC
    Genet Mol Res; 2017 Aug; 16(3):. PubMed ID: 28829890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiproliferative and Pro-Apoptotic Effects of MiR-4286 Inhibition in Melanoma Cells.
    Komina A; Palkina N; Aksenenko M; Tsyrenzhapova S; Ruksha T
    PLoS One; 2016; 11(12):e0168229. PubMed ID: 28005927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTEN, A Target of Microrna-374b, Contributes to the Radiosensitivity of Canine Oral Melanoma Cells.
    Noguchi S; Ogusu R; Wada Y; Matsuyama S; Mori T
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile.
    Larsen AC
    Acta Ophthalmol; 2016 May; 94 Thesis 1():1-27. PubMed ID: 27192168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of microRNA-21 and microRNA-125b in melanoma tissue.
    Wandler A; Riber-Hansen R; Hager H; Hamilton-Dutoit SJ; Schmidt H; Nielsen BS; Stougaard M; Steiniche T
    Melanoma Res; 2017 Oct; 27(5):417-428. PubMed ID: 28614272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative reciprocity of NRAS and PTEN/MMAC1 alterations in cutaneous melanoma cell lines.
    Tsao H; Zhang X; Fowlkes K; Haluska FG
    Cancer Res; 2000 Apr; 60(7):1800-4. PubMed ID: 10766161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of MicroRNA-301a and its Functional Roles in Malignant Melanoma.
    Cui L; Li Y; Lv X; Li J; Wang X; Lei Z; Li X
    Cell Physiol Biochem; 2016; 40(1-2):230-244. PubMed ID: 27855389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.